157 related articles for article (PubMed ID: 35760756)
21. Dipeptidyl peptidase 8/9-like activity in human leukocytes.
Maes MB; Dubois V; Brandt I; Lambeir AM; Van der Veken P; Augustyns K; Cheng JD; Chen X; Scharpé S; De Meester I
J Leukoc Biol; 2007 May; 81(5):1252-7. PubMed ID: 17287297
[TBL] [Abstract][Full Text] [Related]
22. Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins.
Wagner L; Klemann C; Stephan M; von Hörsten S
Clin Exp Immunol; 2016 Jun; 184(3):265-83. PubMed ID: 26671446
[TBL] [Abstract][Full Text] [Related]
23. Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.
Lu IL; Lee SJ; Tsu H; Wu SY; Kao KH; Chien CH; Chang YY; Chen YS; Cheng JH; Chang CN; Chen TW; Chang SP; Chen X; Jiaang WT
Bioorg Med Chem Lett; 2005 Jul; 15(13):3271-5. PubMed ID: 15927466
[TBL] [Abstract][Full Text] [Related]
24. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
[TBL] [Abstract][Full Text] [Related]
25. DPP9 Comes of Age: Highly Selective Inhibitors Promise New Therapeutic Opportunities.
Jiménez VA
J Med Chem; 2023 Sep; 66(18):12715-12716. PubMed ID: 37721863
[TBL] [Abstract][Full Text] [Related]
26. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
Zhang H; Chen Y; Keane FM; Gorrell MD
Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
[TBL] [Abstract][Full Text] [Related]
27. Enzyme activity and immunohistochemical localization of dipeptidyl peptidase 8 and 9 in male reproductive tissues.
Dubois V; Van Ginneken C; De Cock H; Lambeir AM; Van der Veken P; Augustyns K; Chen X; Scharpé S; De Meester I
J Histochem Cytochem; 2009 Jun; 57(6):531-41. PubMed ID: 19188489
[TBL] [Abstract][Full Text] [Related]
28. The amino-dipeptidyl peptidases DPP8 and DPP9: Purification and enzymatic assays.
Donzelli L; Bolgi O; Geiss-Friedlander R
Methods Enzymol; 2023; 684():289-323. PubMed ID: 37230592
[TBL] [Abstract][Full Text] [Related]
29. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling.
Yao TW; Kim WS; Yu DM; Sharbeen G; McCaughan GW; Choi KY; Xia P; Gorrell MD
Mol Cancer Res; 2011 Jul; 9(7):948-59. PubMed ID: 21622624
[TBL] [Abstract][Full Text] [Related]
30. Substituted 4-carboxymethylpyroglutamic acid diamides as potent and selective inhibitors of fibroblast activation protein.
Tsai TY; Yeh TK; Chen X; Hsu T; Jao YC; Huang CH; Song JS; Huang YC; Chien CH; Chiu JH; Yen SC; Tang HK; Chao YS; Jiaang WT
J Med Chem; 2010 Sep; 53(18):6572-83. PubMed ID: 20718420
[TBL] [Abstract][Full Text] [Related]
31. Dipeptidyl peptidase 9 (DPP9) in human skin cells.
Gabrilovac J; Čupić B; Zapletal E; Kraus O; Jakić-Razumović J
Immunobiology; 2017 Feb; 222(2):327-342. PubMed ID: 27682012
[TBL] [Abstract][Full Text] [Related]
32. Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor.
Wang A; Dorso C; Kopcho L; Locke G; Langish R; Harstad E; Shipkova P; Marcinkeviciene J; Hamann L; Kirby MS
BMC Pharmacol; 2012 Apr; 12():2. PubMed ID: 22475049
[TBL] [Abstract][Full Text] [Related]
33. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
[TBL] [Abstract][Full Text] [Related]
34. 4-Substituted boro-proline dipeptides: synthesis, characterization, and dipeptidyl peptidase IV, 8, and 9 activities.
Wu W; Liu Y; Milo LJ; Shu Y; Zhao P; Li Y; Woznica I; Yu G; Sanford DG; Zhou Y; Poplawski SE; Connolly BA; Sudmeier JL; Bachovchin WW; Lai JH
Bioorg Med Chem Lett; 2012 Sep; 22(17):5536-40. PubMed ID: 22853995
[TBL] [Abstract][Full Text] [Related]
35. 2-[3-[2-[(2S)-2-Cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]- 1,2,3,4-tetrahydroisoquinoline: a potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV.
Tsu H; Chen X; Chen CT; Lee SJ; Chang CN; Kao KH; Coumar MS; Yeh YT; Chien CH; Wang HS; Lin KT; Chang YY; Wu SH; Chen YS; Lu IL; Wu SY; Tsai TY; Chen WC; Hsieh HP; Chao YS; Jiaang WT
J Med Chem; 2006 Jan; 49(1):373-80. PubMed ID: 16392822
[TBL] [Abstract][Full Text] [Related]
36. An example of designed multiple ligands spanning protein classes: dual MCH-1R antagonists/DPPIV inhibitors.
Gattrell WT; Sambrook Smith CP; Smith AJ
Bioorg Med Chem Lett; 2012 Apr; 22(7):2464-9. PubMed ID: 22377519
[TBL] [Abstract][Full Text] [Related]
37. Chemoproteomics-Enabled Identification of 4-Oxo-β-Lactams as Inhibitors of Dipeptidyl Peptidases 8 and 9.
Carvalho LAR; Ross B; Fehr L; Bolgi O; Wöhrle S; Lum KM; Podlesainski D; Vieira AC; Kiefersauer R; Félix R; Rodrigues T; Lucas SD; Groß O; Geiss-Friedlander R; Cravatt BF; Huber R; Kaiser M; Moreira R
Angew Chem Int Ed Engl; 2022 Nov; 61(47):e202210498. PubMed ID: 36089535
[TBL] [Abstract][Full Text] [Related]
38. Profibrotic mechanisms of DPP8 and DPP9 highly expressed in the proximal renal tubule epithelial cells.
Zhang Y; Li K; Li Y; Zhao W; Wang L; Chen Z; Ma X; Yao T; Wang J; Dong W; Li X; Tian X; Fu R
Pharmacol Res; 2021 Jul; 169():105630. PubMed ID: 33932609
[TBL] [Abstract][Full Text] [Related]
39. Non-Specific Inhibition of Dipeptidyl Peptidases 8/9 by Dipeptidyl Peptidase 4 Inhibitors Negatively Affects Mesenchymal Stem Cell Differentiation.
Torrecillas-Baena B; Camacho-Cardenosa M; Quesada-Gómez JM; Moreno-Moreno P; Dorado G; Gálvez-Moreno MÁ; Casado-Díaz A
J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510747
[TBL] [Abstract][Full Text] [Related]
40. Prolyl peptidases related to dipeptidyl peptidase IV: potential of specific inhibitors in drug discovery.
Van der Veken P; Haemers A; Augustyns K
Curr Top Med Chem; 2007; 7(6):621-35. PubMed ID: 17352682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]